These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8299739

  • 21. Differential effect of natural killer cells on modulating CFU-Meg and BFU-E proliferation in situ.
    Pantel K, Nakeff A.
    Exp Hematol; 1989 Nov; 17(10):1017-21. PubMed ID: 2806434
    [Abstract] [Full Text] [Related]

  • 22. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V, Ferguson KF, Heller G, Kernan NA.
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [Abstract] [Full Text] [Related]

  • 23. Purification of murine bone-marrow-derived granulocyte-macrophage colony-forming cells.
    Williams DE, Straneva JE, Shen RN, Broxmeyer HE.
    Exp Hematol; 1987 Mar; 15(3):243-50. PubMed ID: 3817051
    [Abstract] [Full Text] [Related]

  • 24. In vitro expansion of murine hematopoietic progenitor cells by leukemia inhibitory factor, stem cell factor, and interleukin-1 beta.
    Imamura M, Zhu X, Han M, Kobayashi M, Hashino S, Tanaka J, Kobayashi S, Kasai M, Asaka M.
    Exp Hematol; 1996 Sep; 24(11):1280-8. PubMed ID: 8862438
    [Abstract] [Full Text] [Related]

  • 25. Macrophage inflammatory protein: its characteristics, biological properties and role in the regulation of haemopoiesis.
    Lord BI, Heyworth CM, Woolford LB.
    Int J Hematol; 1993 Jun; 57(3):197-206. PubMed ID: 8364183
    [Abstract] [Full Text] [Related]

  • 26. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL, Rebel VI, Lemieux ME, Helgason CD, Lansdorp PM, Eaves CJ.
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [Abstract] [Full Text] [Related]

  • 27. Differential response of CD34+ cells isolated from cord blood and bone marrow to MIP-1 alpha and the expression of MIP-1 alpha receptors on these immature cells.
    de Wynter EA, Durig J, Cross MA, Heyworth CM, Testa NG.
    Stem Cells; 1998 Feb; 16(5):349-56. PubMed ID: 9766815
    [Abstract] [Full Text] [Related]

  • 28. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W, Goris H, Dontje B, Dresz J, Loeffler M.
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [Abstract] [Full Text] [Related]

  • 29. Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo.
    Broxmeyer HE, Gentile P, Cooper S, Lu L, Juliano L, Piacibello W, Meyers PA, Cavanna F.
    Blood Cells; 1984 Apr; 10(2-3):397-426. PubMed ID: 6543656
    [Abstract] [Full Text] [Related]

  • 30. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.
    Kaushansky K, Lin N, Grossmann A, Humes J, Sprugel KH, Broudy VC.
    Exp Hematol; 1996 Feb; 24(2):265-9. PubMed ID: 8641351
    [Abstract] [Full Text] [Related]

  • 31. Hemopoietic effects of intravenous soluble glucan administration.
    Patchen ML, MacVittie TJ.
    J Immunopharmacol; 1986 Feb; 8(3):407-25. PubMed ID: 3760593
    [Abstract] [Full Text] [Related]

  • 32. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE, Cooper S, Hangoc G, Chang CH.
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [Abstract] [Full Text] [Related]

  • 33. Macrophage inflammatory protein-1 alpha rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes.
    Zhou Z, Kim YJ, Pollok K, Hurtado J, Lee JK, Broxmeyer HE, Kwon BS.
    J Immunol; 1993 Oct 15; 151(8):4333-41. PubMed ID: 8409405
    [Abstract] [Full Text] [Related]

  • 34. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
    Broxmeyer HE, Cooper S, Rubin BY, Taylor MW.
    J Immunol; 1985 Oct 15; 135(4):2502-6. PubMed ID: 3928752
    [Abstract] [Full Text] [Related]

  • 35. Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo.
    Alam R, Kumar D, Anderson-Walters D, Forsythe PA.
    J Immunol; 1994 Feb 01; 152(3):1298-303. PubMed ID: 8301133
    [Abstract] [Full Text] [Related]

  • 36. Specificity and reciprocity in the interactions between TGF-beta and macrophage inflammatory protein-1 alpha.
    Maltman J, Pragnell IB, Graham GJ.
    J Immunol; 1996 Feb 15; 156(4):1566-71. PubMed ID: 8568261
    [Abstract] [Full Text] [Related]

  • 37. In vivo and in vitro effects of 3-hydroxypyridin-4-one chelators on murine hemopoiesis.
    Hoyes KP, Jones HM, Abeysinghe RD, Hider RC, Porter JB.
    Exp Hematol; 1993 Jan 15; 21(1):86-92. PubMed ID: 8417963
    [Abstract] [Full Text] [Related]

  • 38. Mobilization of peripheral blood progenitor cells by Betafectin PGG-Glucan alone and in combination with granulocyte colony-stimulating factor.
    Patchen ML, Liang J, Vaudrain T, Martin T, Melican D, Zhong S, Stewart M, Quesenberry PJ.
    Stem Cells; 1998 Jan 15; 16(3):208-17. PubMed ID: 9617896
    [Abstract] [Full Text] [Related]

  • 39. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
    Karlic H, Louda N, Pfeilstöcker M, Keil F, Lohninger A, Pittermann E, Paukovits J.
    Stem Cells; 2001 Jan 15; 19(4):321-8. PubMed ID: 11463952
    [Abstract] [Full Text] [Related]

  • 40. Influence of purified recombinant human macrophage colony stimulating factor in mice.
    Broxmeyer HE, Geissler K, Cooper S, Williams DE.
    Biotechnol Ther; 2001 Jan 15; 1(1):43-54. PubMed ID: 2562643
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.